337355-81-4 Usage
Uses
Used in Pharmaceutical Industry:
3-(4-Benzyloxy-phenyl)-isoxazole-5-carbaldehyde is used as a building block for the development of medicinal compounds due to its unique structure and reactivity, which can be leveraged to create new drugs with potential therapeutic effects.
Used in Research and Development:
In the field of research and development, 3-(4-Benzyloxy-phenyl)-isoxazole-5-carbaldehyde is utilized for the synthesis of novel molecules with potential biological activity. Its presence in various organic synthesis reactions allows for the exploration of new chemical entities that could have applications in medicine and other fields.
Used in Organic Synthesis:
3-(4-Benzyloxy-phenyl)-isoxazole-5-carbaldehyde is used as a key intermediate in organic synthesis, where its benzyl ether and aldehyde functional groups facilitate the creation of a wide range of organic molecules for various applications, including but not limited to pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 337355-81-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,7,3,5 and 5 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 337355-81:
(8*3)+(7*3)+(6*7)+(5*3)+(4*5)+(3*5)+(2*8)+(1*1)=154
154 % 10 = 4
So 337355-81-4 is a valid CAS Registry Number.
337355-81-4Relevant academic research and scientific papers
SUBSTITUTED AZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVES, AND METHOD FOR TREATING PARKINSON'S DISEASE USING THE SAME
-
Paragraph 782-783, (2010/09/17)
Provided are a substituted azole derivative and pharmaceutically acceptable salts thereof, a pharmaceutical composition including an effective amount of the derivative, and a method for treating Parkinson's disease in a mammal including administering an e
Synthesis and biological evaluation of novel T-type Ca2+ channel blockers
Jung, Hee Kyung,Doddareddy, Munikumar Reddy,Cha, Joo Hwan,Rhim, Hyewhon,Cho, Yong Seo,Koh, Hun Yeong,Jung, Bong Young,Pae, Ae Nim
, p. 3965 - 3970 (2007/10/03)
A small molecule library of piperazinylalkylisoxazole derivatives containing about 600 compounds was designed, synthesized and evaluated for blocking effects on T-type Ca2+ channel. Several ligands were identified to possess high inhibitory activity against the T-type Ca 2+ channel. The compound 21 with trifluoromethyl substituents at C3-position of phenyl group (R1) and C2- position of phenyl group (R2) showed the highest inhibitory activity with IC50 value of 1.02μM, which is comparable to that of mibefradil.
